RECRUITINGPhase 1 / Phase 2INTERVENTIONAL
Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients
Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients With Intraabdominal Sepsis: A Randomized Controlled Study
About This Trial
Inflammatory response and hemodynamic response in patients with intraabdominal sepsis and Effects of Dexmedetomidine versus ketamine on it .
Who May Be Eligible (Plain English)
Who May Qualify:
- • Adult patients admitted to ICU after ileus surgery (perforated viscus, infarcted bowel, strangulated hernia, anastomotic leakage, diverticulitis, and intestinal obstruction), and who will be expected to require postoperative sedation and ventilation.
- Abdominal sepsis was determined as organ dysfunction with a substantial change in overall SOFA score (2) ≥ 2 points because of intra-abdominal sepsis.
Who Should NOT Join This Trial:
- • Known allergy to ketamine, dexmedetomidine,
- Confirmed pregnancy,
- Heart failure (class 3 or 4 of the New York Heart Association),
- Renal failure (RIFLE classification),
- Liver failure (manifested by serum total protein concentration \<3 g/dl and total bilirubin \>5 mg/dl)
- Known or suspected brain death.
- Patients who receive neuromuscular blockers during the first 48 hours of ICU admission will also be excluded.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* • Adult patients admitted to ICU after ileus surgery (perforated viscus, infarcted bowel, strangulated hernia, anastomotic leakage, diverticulitis, and intestinal obstruction), and who will be expected to require postoperative sedation and ventilation.
* Abdominal sepsis was determined as organ dysfunction with a substantial change in overall SOFA score (2) ≥ 2 points because of intra-abdominal sepsis.
Exclusion Criteria:
* • Known allergy to ketamine, dexmedetomidine,
* Confirmed pregnancy,
* Heart failure (class 3 or 4 of the New York Heart Association),
* Renal failure (RIFLE classification),
* Liver failure (manifested by serum total protein concentration \<3 g/dl and total bilirubin \>5 mg/dl)
* Known or suspected brain death.
* Patients who receive neuromuscular blockers during the first 48 hours of ICU admission will also be excluded.
Treatments Being Tested
DRUG
Dexmedetomidine
Patients will receive dexmedetomidine
DRUG
Ketamine
patients Will receive ketamine
Locations (1)
asyut University
Asyut, Egypt